Ekf Diagnostics Holding PLC (LON:EKF)‘s stock had its “buy” rating reaffirmed by analysts at Panmure Gordon in a report released on Monday. They presently have a GBX 19 ($0.24) price objective on the stock. Panmure Gordon’s price target indicates a potential upside of 10.14% from the company’s previous close.
EKF has been the subject of a number of other research reports. FinnCap restated an “under review” rating on shares of Ekf Diagnostics Holding PLC in a report on Tuesday, August 30th. N+1 Singer restated a “corporate” rating on shares of Ekf Diagnostics Holding PLC in a report on Friday, October 7th.
Shares of Ekf Diagnostics Holding PLC (LON:EKF) opened at 17.25 on Monday. Ekf Diagnostics Holding PLC has a 12 month low of GBX 7.75 and a 12 month high of GBX 18.24. The stock has a 50 day moving average price of GBX 16.92 and a 200 day moving average price of GBX 14.57. The stock’s market cap is GBX 73.96 million.